Literature DB >> 10800284

Mutation analysis of BRCA1 gene in African-American patients with breast cancer.

D Shen1, Y Wu, M Subbarao, H Bhat, R Chillar, J V Vadgama.   

Abstract

An estimated 7% of all breast cancers and 10% of all ovarian cancers are associated with inherited mutations in BRCA1 and BRCA2 genes. The mutations of a breast cancer-susceptible gene, BRCA1, confers increased risk of breast cancer in young women. Numerous studies have reported specific mutations in the BRCA1 and BRCA2 genes in the white population. However, there are very few studies on African-American and other ethnic minority groups. The goal of this study is to identify whether African-American patients with breast cancer carry some common mutations reported in other ethnic groups and whether they carry some novel mutations. We screened hot-region mutations on exons 2, 5, 11, 16, and 20 of BRCA1 gene in 54 African-American patients with breast cancer by NIRCA and SSCP methods. Our data revealed one novel frameshift mutation (3331 insG) and three missense sequence variants (A3537G, A3667G, and C4009T) on exon 11. Each sequence change was confirmed by automatic DNA sequencing. One rare sequence variant, A3537G, has been revealed in high frequency (3/54). Our data suggested that African-American patients with breast cancer carry some unique BRCA1 gene mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800284      PMCID: PMC2640500     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  33 in total

1.  Resolving DNA mutations.

Authors:  M Dean
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

2.  Racial disparity in the association of p53 gene alterations with breast cancer survival.

Authors:  Y H Shiao; V W Chen; W D Scheer; X C Wu; P Correa
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

3.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

4.  Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

Authors:  O Johannsson; E A Ostermeyer; S Håkansson; L S Friedman; U Johansson; G Sellberg; K Brøndum-Nielsen; V Sele; H Olsson; M C King; A Borg
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

5.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

6.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Authors:  M G FitzGerald; D J MacDonald; M Krainer; I Hoover; E O'Neil; H Unsal; S Silva-Arrieto; D M Finkelstein; P Beer-Romero; C Englert; D C Sgroi; B L Smith; J W Younger; J E Garber; R B Duda; K A Mayzel; K J Isselbacher; S H Friend; D A Haber
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

7.  BRCA1 mutations in a population-based sample of young women with breast cancer.

Authors:  A A Langston; K E Malone; J D Thompson; J R Daling; E A Ostrander
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

8.  Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Authors:  W D Foulkes; N Wong; J S Brunet; L R Bégin; J C Zhang; J J Martinez; F Rozen; P N Tonin; S A Narod; S E Karp; M N Pollak
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

10.  Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer.

Authors:  H Blaszyk; C B Vaughn; A Hartmann; R M McGovern; J J Schroeder; J Cunningham; D Schaid; S S Sommer; J S Kovach
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

View more
  7 in total

1.  BRCA1 variants in a family study of African-American and Latina women.

Authors:  Roberta McKean-Cowdin; Heather Spencer Feigelson; Lucy Y Xia; Celeste Leigh Pearce; Duncan C Thomas; Daniel O Stram; Brian E Henderson
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

2.  Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned.

Authors:  Susan T Vadaparampil; Tuya Pal
Journal:  J Community Genet       Date:  2010-05-23

3.  Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer.

Authors:  Orland Diez; Amadeu Pelegrí; Neus Gadea; Sara Gutiérrez-Enríquez; Miriam Masas; Anna Tenés; Nina Bosch; Judith Balmaña; Begoña Graña
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

4.  Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature.

Authors:  Makiko Kunogi; Masatoshi Kurihara; Takako Shigihara Ikegami; Toshiyuki Kobayashi; Noriko Shindo; Toshio Kumasaka; Yoko Gunji; Mika Kikkawa; Shin-ichiro Iwakami; Okio Hino; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  J Med Genet       Date:  2010-04       Impact factor: 6.318

5.  BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.

Authors:  Tara M Friebel; Irene L Andrulis; Judith Balmaña; Amie M Blanco; Fergus J Couch; Mary B Daly; Susan M Domchek; Douglas F Easton; William D Foulkes; Patricia A Ganz; Judy Garber; Gord Glendon; Mark H Greene; Peter J Hulick; Claudine Isaacs; Rachel C Jankowitz; Beth Y Karlan; Judy Kirk; Ava Kwong; Annette Lee; Fabienne Lesueur; Karen H Lu; Katherine L Nathanson; Susan L Neuhausen; Kenneth Offit; Edenir I Palmero; Priyanka Sharma; Marc Tischkowitz; Amanda E Toland; Nadine Tung; Elizabeth J van Rensburg; Ana Vega; Jeffrey N Weitzel; Gemo Study Collaborators; Kent F Hoskins; Tara Maga; Michael T Parsons; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Dezheng Huo; Olufunmilayo I Olopade; Timothy R Rebbeck
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.700

6.  Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review.

Authors:  Kerry A Sherman; Suzanne M Miller; Laura-Kate Shaw; Karen Cavanagh; Sherri Sheinfeld Gorin
Journal:  J Community Genet       Date:  2013-08-10

7.  Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.

Authors:  Man Yee Keung; Yanyuan Wu; Francesca Badar; Jaydutt V Vadgama
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.